Publications

Use the search tool below to browse peer-reviewed published articles on or related to Jazz's approved and investigational products. Please note, publications related to Jazz's approved product may contain information about dosing or use of a Jazz product that is different from the approved use(s). Jazz does not recommend the use of any of its products in any manner that listed in the product Prescribing Information, which is displayed as part of this search tool. Publications on Jazz's investigational products are provided for information only. Under no circumstances does Jazz promote use of a product without a licensed indication. If you have any questions about information in a publication or wish to access a publication not listed below, please contact Jazz Medical Information via the link below.

Product

Clear selection Defitelio® (defibrotide) Epidiolex® (cannabidiol) Rylaze® (asparaginase erwinia chrysanthemi (recombinant) rywn) injection Vyxeos® (daunorubicin and cytarabine) Xywav® (calcium, magnesium, potassium, and sodium oxybates) oral solution, CIII Ziihera® (zanidatamab) Zepzelca® (lurbinectedin)

Filter by keywords

Publication

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

Published: April 09, 2022

Authors: Orrin Devinsky, J Helen Cross, Linda Laux et al.

Publication

A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment.

Published: March 02, 2022

Authors: Bola Tayo, Lesley Taylor, Farhad Sahebkar et al.

Publication

Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences.

Published: February 02, 2022

Authors: Michael J Burke, Beata Zalewska-Szewczyk

Publication

Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial.

Published: January 11, 2022

Authors: Elizabeth A Thiele, E Martina Bebin, Hari Bhathal et al.

Publication

Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial.

Published: December 27, 2021

Authors: Elizabeth A Thiele, E Martina Bebin, Francis Filloux et al.

Publication

Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomnia.

Published: November 24, 2021

Authors: Gunjan Junnarkar, Clark Allphin, Judi Profant et al.

Publication

Patient and Caregiver Health State Utilities in Lennox-Gastaut Syndrome and Dravet Syndrome.

Published: November 11, 2021

Authors: Siu Hing Lo, Andrew Lloyd, Jade Marshall et al.

Publication

Impact of developmental and epileptic encephalopathies on caregivers: A literature review.

Published: October 01, 2021

Authors: Katy Gallop, Andrew J Lloyd, Jennifer Olt et al.

Publication

Patient and Caregiver Health State Utilities in Tuberous Sclerosis Complex.

Published: September 15, 2021

Authors: Siu Hing Lo, Jade Marshall, Hanna Skrobanski et al.

Publication

Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial.

Published: August 18, 2021

Authors: Ingrid E Scheffer, Jonathan J Halford, Ian Miller et al.

Disclaimer

This AI model is continuing to learn and its responses are based on learned data patterns. It should not replace professional judgment. Please verify the information before use, and feedback is welcome to improve its accuracy.

Please do not include personal or confidential information in your searches. For information on how to report an adverse event or product complaint for a Jazz product, please visit: https://www.jazzpharma.com/medicines/drug-safety/.